<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Infectious diseases</title>
            <link>https://medicalxpress.com/infectious-diseases-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Infectious diseases</description>

                            <item>
                    <title>Blood pressure drug effective for treating antibiotic-resistant bacteria, study finds</title>
                    <description>Infections from antibiotic-resistant bacteria are difficult to treat and are responsible for over 2.8 million infections and more than 35,000 deaths in the U.S. each year. A new study in Nature Communications reports that a drug used to lower blood pressure could also be the basis of a promising new treatment for methicillin-resistant Staphylococcus aureus (MRSA).</description>
                    <link>https://medicalxpress.com/news/2026-04-blood-pressure-drug-effective-antibiotic.html</link>
                    <category></category>
                    <pubDate>Fri, 17 Apr 2026 14:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news695650442</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/houston-methodist-stud.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Long-term cure rates for multidrug-resistant tuberculosis much better than expected</title>
                    <description>A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly higher than previous standard indicators suggest. The results, published in The Lancet Regional Health Europe, are based on the analysis of data from 1,299 adult patients treated between 2005 and 2021. The study was in collaboration with researchers from the clinical tuberculosis infrastructure (ClinTB) at the German Center for Infection Research (DZIF) at the Research Center Borstel, Leibniz Lung Center (FZB).</description>
                    <link>https://medicalxpress.com/news/2026-04-term-multidrug-resistant-tuberculosis.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 17:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news695575021</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/long-term-cure-rates-f.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>The cold virus &#039;hides&#039; and multiplies in the tonsils and adenoids, even in people without symptoms</title>
                    <description>A study conducted at the University of São Paulo (USP) in Brazil reveals that tissues such as the tonsils and adenoids can serve as hiding places for the rhinovirus, which causes the common cold and is responsible for most respiratory infections worldwide. Using samples from 293 children who underwent surgery to remove these tissues, the study showed that the pathogen can infect immune cells known as lymphocytes and remain there for long periods without causing symptoms. This allows the virus to potentially be transmitted to others without warning. The findings are published in the Journal of Medical Virology.</description>
                    <link>https://medicalxpress.com/news/2026-04-cold-virus-tonsils-adenoids-people.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 15:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news695569141</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/rhinovirus.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Programming the immune system to manufacture its own therapeutic proteins</title>
                    <description>An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including certain kinds of highly potent antibodies that are naturally difficult to produce—by reprogramming the immune system itself.</description>
                    <link>https://medicalxpress.com/news/2026-04-immune-therapeutic-proteins.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 14:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news695550288</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/immune-reprogramming.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Skin cells may help rabies invade nerves after minor bites or scratches</title>
                    <description>While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to pass through, novel research reveals that these cells play a much more active role. The findings of a new study in the Journal of Investigative Dermatology (JID), provide direct evidence that keratinocytes can support viral replication and transmit the rabies virus to neurons.</description>
                    <link>https://medicalxpress.com/news/2026-04-skin-cells-rabies-invade-nerves.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 00:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news695477521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/novel-research-reveals.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Gut microbiome serves as key driver of bacterial infection outcomes in fatty liver disease</title>
                    <description>A research team led by the University of California, Irvine&#039;s Joe C. Wen School of Population &amp; Public Health has uncovered a critical biological link explaining why individuals with metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease) face significantly worse outcomes from certain foodborne infections. The study published in Gut Microbes is the first to show how changes in the connection between the gut and liver can make foodborne infections more severe—an illness that is becoming a growing global health concern.</description>
                    <link>https://medicalxpress.com/news/2026-04-gut-microbiome-key-driver-bacterial.html</link>
                    <category></category>
                    <pubDate>Wed, 15 Apr 2026 19:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news695486702</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/gut-microbiome-serves.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A better flu shot may be coming: How epitope targeting could widen protection</title>
                    <description>Doctors recommend getting your flu shot annually, since the specific influenza strain it targets varies from year to year. But what if the shot could be more effective while protecting against more strains? Researchers from the University of Missouri School of Medicine are one step closer to making this happen. When the immune system sees a new strain of a familiar virus, it typically focuses on the parts it &quot;remembers&quot; most, even if those regions have changed. &quot;Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination&quot; was recently published in Nature Communications.</description>
                    <link>https://medicalxpress.com/news/2026-04-flu-shot-epitope-widen.html</link>
                    <category></category>
                    <pubDate>Wed, 15 Apr 2026 19:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news695491082</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/targeting-distinct-reg.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>As syphilis cases rise, study links infection with higher risk of stroke, heart attack and other serious problems</title>
                    <description>Syphilis has been rising sharply in the United States, with especially high rates in Southern states. Now, a new study from Tulane University researchers suggests the long-term infection may carry another risk that is often overlooked: serious damage to the heart and blood vessels.</description>
                    <link>https://medicalxpress.com/news/2026-04-syphilis-cases-links-infection-higher.html</link>
                    <category></category>
                    <pubDate>Wed, 15 Apr 2026 14:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news695481422</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/syphilis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Genome-wide analysis reveals host–virus genetic interactions in cancer risk</title>
                    <description>A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions between human and viral genomes shape disease risk. The research found that variations in the Epstein–Barr virus, together with a specific immune-related gene (HLA-A*11:01), strongly influence the risk of nasopharyngeal cancer. The findings are published in Nature.</description>
                    <link>https://medicalxpress.com/news/2026-04-genome-wide-analysis-reveals-hostvirus.html</link>
                    <category></category>
                    <pubDate>Wed, 15 Apr 2026 11:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695394841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/genome.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Taking a closer look at immune &#039;memory&#039; could spur progress in the fight against lethal illnesses</title>
                    <description>The average human has about 1.8 trillion immune cells. These cells patrol the body for bacteria, viruses, cancers, and other threats. Vaccines enhance this security system by teaching our immune cells to target specific pathogens. According to the World Health Organization, vaccine-induced immunity saves about six lives every minute. But how long does this protective immune &quot;memory&quot; last?</description>
                    <link>https://medicalxpress.com/news/2026-04-closer-immune-memory-spur-lethal.html</link>
                    <category></category>
                    <pubDate>Tue, 14 Apr 2026 17:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news695403061</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/were-taking-a-closer-l.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ultrasensitive test reveals evidence of previously undetected tuberculosis in hospital patients</title>
                    <description>Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized in Boston, suggesting that tuberculosis disease may be significantly underdiagnosed in the United States. The findings, published in Nature Communications, could reshape how clinicians approach tuberculosis (TB) detection and help accelerate progress toward elimination goals.</description>
                    <link>https://medicalxpress.com/news/2026-04-ultrasensitive-reveals-evidence-previously-undetected.html</link>
                    <category></category>
                    <pubDate>Tue, 14 Apr 2026 05:00:07 EDT</pubDate>
                    <guid isPermaLink="false">news695293382</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/nihlaunchesl.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why some vaccine side effects may be avoidable without weakening protection</title>
                    <description>Vaccines play a critical role in preventing infectious diseases, but their success often depends on adjuvants—substances that enhance immune responses. While these compounds improve vaccine effectiveness, they can also trigger reactogenicity, such as local swelling or fever. For decades, scientists have assumed that these beneficial and adverse effects are closely linked, making it difficult to improve one without affecting the other.</description>
                    <link>https://medicalxpress.com/news/2026-04-vaccine-side-effects-weakening.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 19:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news695318882</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-uncover-how-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers demonstrate drug&#039;s effectiveness in drawing out dormant HIV from immune cells</title>
                    <description>Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive in certain areas of the body called latent reservoirs. If treatment is discontinued, these reservoirs may become active again, causing patients to face renewed challenges with symptoms of acquired immunodeficiency syndrome (AIDS).</description>
                    <link>https://medicalxpress.com/news/2026-04-drug-effectiveness-dormant-hiv-immune.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 17:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news695315881</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-demonstrat-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Norway&#039;s &#039;Oslo patient&#039; reaches HIV remission after rare stem cell transplant donated by brother</title>
                    <description>A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.</description>
                    <link>https://medicalxpress.com/news/2026-04-norway-oslo-patient-hiv-remission.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 16:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news695314193</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/1-hiv.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Inhaled RNA therapy cuts lung inflammation after severe infections in preclinical tests</title>
                    <description>NTU Singapore is working with China&#039;s Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at helping patients recover faster from severe lung infections. The treatment is designed to reduce excessive inflammation in the lungs, which can continue even after viruses or bacteria have been cleared from the body.</description>
                    <link>https://medicalxpress.com/news/2026-04-inhaled-rna-therapy-lung-inflammation.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 15:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news695309641</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/lung.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cats are opening a powerful new front in the fight to understand virus-caused cancer</title>
                    <description>Cats are not just beloved companions; they are emerging as key &quot;research partners&quot; in unraveling viral cancer mechanisms. A team led by Professor Julia Beatty, Chair Professor of Veterinary Medicine and Infectious Diseases at Jockey Club College of Veterinary Medicine and Life Sciences of City University of Hong Kong (CityUHK), recently published a review in the journal Nature Reviews Cancer. Titled &quot;Cat viruses as windows into human oncogenesis,&quot; the article explores how feline tumor viruses offer vital insights into human oncology and viral carcinogenesis from a comparative oncology perspective.</description>
                    <link>https://medicalxpress.com/news/2026-04-cats-powerful-front-virus-cancer.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 15:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news695306756</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/from-cats-to-humans-ci.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>End of community-wide treatment linked to resurgence of parasitic worm infections in Malawi</title>
                    <description>Researchers at Liverpool School of Tropical Medicine have found that stopping mass drug administration for Lymphatic Filariasis (LF) was associated with an increase in infections from other parasitic worms, threatening disease control efforts. The study, published in PLOS Neglected Tropical Diseases, suggests that once wider community treatment programs for LF ended, school-aged children were nearly twice as likely to be infected with the intestinal roundworm Ascaris lumbricoides.</description>
                    <link>https://medicalxpress.com/news/2026-04-community-wide-treatment-linked-resurgence.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 12:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news695301481</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/end-of-community-wide-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Obesity can derail vaccine response, forcing lung T cells to defend instead</title>
                    <description>New findings reveal that obesity significantly impaired the quality and longevity of antibody responses to a Pseudomonas aeruginosa vaccine in a mouse model. The impaired antibody production was due to defects in germinal centers, a transient part of the immune system where specialized immune cells, called B cells, produce antibodies and build memory against pathogens.</description>
                    <link>https://medicalxpress.com/news/2026-04-obesity-derail-vaccine-response-lung.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 09:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news695035117</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/12-vaccine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Fighting malaria more effectively with climate data</title>
                    <description>In many parts of East Africa, small pools of water that form after heavy rainfall are ideal breeding sites for the Anopheles mosquitoes that transmit malaria. Researchers at the Karlsruhe Institute of Technology (KIT) have analyzed how such environmental conditions affect the effectiveness of mosquito nets. They combined high-resolution climate and hydrology models with malaria data from Kenya to enable better assessments of when and where the nets are especially effective at preventing infections. Their results have been published in Scientific Reports.</description>
                    <link>https://medicalxpress.com/news/2026-04-malaria-effectively-climate.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 08:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news695287801</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/anopheles-mosquito.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New yellow fever vaccine matches safety and effectiveness of current shot</title>
                    <description>Yellow fever is a viral disease that is spread to humans through the bites of infected mosquitoes. The symptoms range from mild fever-like aches and pains to severe liver disease with bleeding, often accompanied by yellowing skin and eyes. As of now, we do not have antiviral drugs to cure these diseases, as most of the treatments are limited to easing symptoms. Hence, prevention via vaccination is our best bet against this disease. A recent study has found that a new yellow fever vaccine, called vYF by Sanofi, works just as well as the current licensed vaccine, YF-VAX.</description>
                    <link>https://medicalxpress.com/news/2026-04-yellow-fever-vaccine-safety-effectiveness.html</link>
                    <category></category>
                    <pubDate>Sat, 11 Apr 2026 02:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news695041269</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/vaccine-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>COVID-19&#039;s lingering shadow: The molecular link between SARS-CoV-2 and lung cancer risk</title>
                    <description>A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in the lungs, driven by the virus&#039;s spike protein, that promotes inflammation, scarring, and tumor-friendly conditions, especially in higher-risk groups like smokers; while the individual risk remains small, the findings are important because they reveal a plausible mechanism and potential targets for prevention and treatment.</description>
                    <link>https://medicalxpress.com/news/2026-04-covid-lingering-shadow-molecular-link.html</link>
                    <category></category>
                    <pubDate>Fri, 10 Apr 2026 13:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695043841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/covid-19s-lingering-sh.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
